Immunic | VTL - Selling And Administration Expenses


Immunic reported $-0.24 in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 2.29M 649.1K Jun/2023
BioMarin Pharmaceutical USD 322.21M 98.79M Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.33M 50K Sep/2025
CSL USD 1.23B 498M Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Grifols EUR 333.1M 157M Sep/2025
Immunic USD -0.24 0.03 Sep/2024
Insmed USD 212.48M 26.11M Dec/2025
Omeros USD 11.32M 2.48M Sep/2024
OraSure Technologies USD -0.06 0.05 Sep/2024
Quidel USD 194.4M 7.5M Dec/2025
Ultragenyx Pharmaceutical USD 89M 2.38M Dec/2025
United Therapeutics USD 190.6M 38.6M Dec/2025
Xoma USD 11M 2.54M Jun/2024